Landmark ACT for ALS Act on President’s Desk

Landmark ACT for ALS Act on President’s Desk

314826

Landmark ACT for ALS Act on President’s Desk

If signed by President Joe Biden, the bipartisan Accelerating Access to Critical Therapies (ACT) for ALS Act will fund crucial research into fast-progressing neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and provide patients with early access to promising treatment candidates. The legislation (HR 3537), which has passed the U.S. House and most recently the Senate, also would create a U.S. Food and Drug Administration (FDA) Rare Neurodegenerative Disease Grant Program to support other research and…

You must be logged in to read/download the full post.